Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 10/20 | 0.46 |
| ▸ | LPL | P06858 | 9/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | AHR | P35869 | 1/20 | 0.37 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.36 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30009533 | 0.92 | LIPG (0.46) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL12424936 | 0.92 | LIPG (0.46) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL31730285 | 0.88 | LIPG (0.48) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL17120271 | 0.86 | LIPG (0.44) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL18371189 | 0.86 | LIPG (0.48) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL31402358 | 0.86 | LIPG (0.48) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL28995622 | 0.85 | LIPG (0.42) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL19106575 | 0.84 | LIPG (0.49) | LIPGLPLIRAK4PRMT5WDR77 | |
| SCHEMBL17268982 | 0.83 | LIPG (0.57) | LIPGLPLCYP1A2IRAK4ALDH1A1 | |
| SCHEMBL2248070 | 0.82 | LIPG (0.49) | LIPGLPLIRAK4PRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116919-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2024-04-11 | — | — | US | disclosed |
| CN-116057062-A | Organic compound and organic electroluminescent element using same | 索路思高新材料有限公司 | 2023-05-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116919-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | OR10J3, PIEZO1, TIMM9 | LIPG 931/4885LPL 691/4885CYP1A2 1697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.